80 related articles for article (PubMed ID: 11089231)
1. Bactericidal assays for fluoroquinolones.
Gootz TD
Methods Mol Biol; 2001; 95():185-94. PubMed ID: 11089231
[No Abstract] [Full Text] [Related]
2. Quinolone interactions with DNA and DNA gyrase.
Shen LL
Methods Mol Biol; 2001; 95():171-84. PubMed ID: 11089230
[No Abstract] [Full Text] [Related]
3. Plasmid DNA supercoiling by DNA gyrase.
Sayer PJ; Goble ML; Oram M; Fisher LM
Methods Mol Biol; 2001; 95():25-33. PubMed ID: 11089216
[No Abstract] [Full Text] [Related]
4. Plasmid curing effect of trovafloxacin.
Brandi L; Falconi M; Ripa S
FEMS Microbiol Lett; 2000 Mar; 184(2):297-302. PubMed ID: 10713437
[TBL] [Abstract][Full Text] [Related]
5. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA.
Fortune JM; Osheroff N
Methods Mol Biol; 2001; 95():275-81. PubMed ID: 11089239
[No Abstract] [Full Text] [Related]
7. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones.
Morrissey I; George JT
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():101-6. PubMed ID: 10824040
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
9. The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues.
Lawrence LE; Wu P; Fan L; Gouveia KE; Card A; Casperson M; Denbleyker K; Barrett JF
J Antimicrob Chemother; 2001 Aug; 48(2):195-201. PubMed ID: 11481288
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
Wu P; Lawrence LE; Denbleyker KL; Barrett JF
Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II-mediated cleavage of plasmid DNA.
Burden DA; Froelich-Ammon SJ; Osheroff N
Methods Mol Biol; 2001; 95():283-9. PubMed ID: 11089240
[No Abstract] [Full Text] [Related]
12. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
[TBL] [Abstract][Full Text] [Related]
13. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
Anderson R; Jooné GK
Chemotherapy; 1993; 39(6):424-31. PubMed ID: 8222871
[TBL] [Abstract][Full Text] [Related]
14. Interactions between fluoroquinolones, Mg2+, DNA and DNA gyrase, studied by phase partitioning in an aqueous two-phase system and by affinity chromatography.
Khac SB; Moreau NJ
J Chromatogr A; 1994 May; 668(1):241-7. PubMed ID: 7516247
[TBL] [Abstract][Full Text] [Related]
15. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
Schedletzky H; Wiedemann B; Heisig P
J Antimicrob Chemother; 1999 May; 43 Suppl B():31-7. PubMed ID: 10382873
[TBL] [Abstract][Full Text] [Related]
16. Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.
Khodursky AB; Peter BJ; Schmid MB; DeRisi J; Botstein D; Brown PO; Cozzarelli NR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9419-24. PubMed ID: 10944214
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity of trovafloxacin (CP-99,219).
Morrissey I
J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
[TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
Cooper MA; Andrews JM; Wise R
J Antimicrob Chemother; 1991 Sep; 28(3):399-405. PubMed ID: 1660046
[TBL] [Abstract][Full Text] [Related]
19. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
20. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Martínez-Martínez L; Fernández F; Perea EJ
J Antimicrob Chemother; 1999 Feb; 43(2):277-9. PubMed ID: 11252335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
